Lexapro

escitalopram oxalate

Tablet (oral) · NDA 021323

Last listed protection ended

May 12, 2026

The FDA listed 1 exclusivity for Lexapro, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities